The hardware and bandwidth for this mirror is donated by dogado GmbH, the Webhosting and Full Service-Cloud Provider. Check out our Wordpress Tutorial.
If you wish to report a bug, or if you are interested in having us mirror your free-software or open-source project, please feel free to contact us at mirror[@]dogado.de.
Set of tools for descriptive analysis of metaproteomics data generated from high-throughput mass spectrometry instruments. These tools allow to cluster peptides and proteins abundance, expressed as spectral counts, and to manipulate them in groups of metaproteins. This information can be represented using multiple visualization functions to portray the global metaproteome landscape and to differentiate samples or conditions, in terms of abundance of metaproteins, taxonomic levels and/or functional annotation. The provided tools allow to implement flexible analytical pipelines that can be easily applied to studies interested in metaproteomics analysis.
Version: | 1.2.2 |
Depends: | R (≥ 3.5.0) |
Imports: | ade4, dendextend, dplyr, ggforce, ggrepel, reshape2, stringr, tidyverse |
Published: | 2021-02-05 |
DOI: | 10.32614/CRAN.package.metaprotr |
Author: | Aaron Millan-Oropeza [aut, cre], Catherine Juste [aut, ctb], Ariane Bassignani [aut, ctb], Céline Henry [aut, ctb] |
Maintainer: | Aaron Millan-Oropeza <aaron.ibt at gmail.com> |
License: | GPL-3 |
URL: | https://forgemia.inra.fr/pappso/metaprotr |
NeedsCompilation: | no |
Materials: | README NEWS |
CRAN checks: | metaprotr results |
Reference manual: | metaprotr.pdf |
Package source: | metaprotr_1.2.2.tar.gz |
Windows binaries: | r-devel: metaprotr_1.2.2.zip, r-release: metaprotr_1.2.2.zip, r-oldrel: metaprotr_1.2.2.zip |
macOS binaries: | r-release (arm64): metaprotr_1.2.2.tgz, r-oldrel (arm64): metaprotr_1.2.2.tgz, r-release (x86_64): metaprotr_1.2.2.tgz, r-oldrel (x86_64): metaprotr_1.2.2.tgz |
Please use the canonical form https://CRAN.R-project.org/package=metaprotr to link to this page.
These binaries (installable software) and packages are in development.
They may not be fully stable and should be used with caution. We make no claims about them.
Health stats visible at Monitor.